MedPath

西藏朋来汇宝医药有限公司

Ownership
-
Established
2023-07-07
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Hypromellose Eye Drops

Product Name
羟丙甲纤维素滴眼液
Approval Number
国药准字H20073657
Approval Date
May 16, 2023
NMPA

Diammonium Glycyrrhizinate for Injection

Product Name
喜心生
Approval Number
国药准字H20051453
Approval Date
Nov 27, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.